@Article{ ALONSO_Riveiro-barciela_FERNANDEZ_Rincón_Real_Llerena_Gea_Olveira_Fernández-carrillo_Polo_Carrión_GOMEZ_Devesa_Baliellas_Castro_Ampuero_Granados_Pascasio_Rubín_SALMERON_Badia_Planas_Lens_Turnes_Montero_Buti_ESTEBAN_Fernández-rodríguez:304-311,

author = { S ALONSO and M Riveiro-barciela and I FERNANDEZ and D Rincón and Y Real and S Llerena and F Gea and A Olveira and C Fernández-carrillo and B Polo and Ja Carrión and A GOMEZ and Mj Devesa and C Baliellas and A Castro and J Ampuero and R Granados and Jm Pascasio and A Rubín and FRANCISCO JAVIER SALMERON ESCOBAR and E Badia and Jm Planas and S Lens and J Turnes and Jl Montero and M Buti and R ESTEBAN and Cm Fernández-rodríguez } ,

title = { Effectiveness and safety of sofosbuvir-based regimens plus an NS5A inhibitor for patients with HCV genotype 3 infection and cirrhosis. Results of a multicenter real-life cohort. },

journal = { Journal of Viral Hepatitis },

year = { 2017 },

volume = { 24 },

pages = { 304-311 },

}